Neural Tube Defects < Neuraminidase < Neurodegenerative Diseases

Facettes : Author.f AffPays.f AffRegion.f AffVille.f

List of bibliographic references

Number of relevant bibliographic references: 125.
[0-20] [0 - 20][0 - 50][20-40]

Ident.	Authors (with country if any)	Title
000174 (2019)	David M. Morens [États-Unis] ; Jeffery K. Taubenberger [États-Unis]	Making Universal Influenza Vaccines: Lessons From the 1918 Pandemic.
000179 (2019)	Chavely Gwladys Monamele [Cameroun] ; Hermann Landry Munshili Njifon [Cameroun] ; Marie-Astrid Vernet [Cameroun] ; Mohamadou Ripa Njankouo [Cameroun] ; Sebastien Kenmoe [Cameroun] ; Ali Ahmed Yahaya ; Louis Deweerdt [Cameroun] ; Raphael Nono [Cameroun] ; Wilfred Mbacham [Cameroun] ; Damian Nota Anong [Cameroun] ; Jane Francis Akoachere [Cameroun] ; Richard Njouom [Cameroun]	Molecular characterization of influenza A(H1N1)pdm09 in Cameroon during the 2014-2016 influenza seasons.
000252 (2018)	César Parra-Rojas [Allemagne] ; Van Kinh Nguyen [Allemagne] ; Gustavo Hernandez-Mejia [Allemagne] ; Esteban A. Hernandez-Vargas [Allemagne]	Neuraminidase Inhibitors in Influenza Treatment and Prevention⁻Is It Time to Call It a Day?
000291 (2018)	Xin Zhao [République populaire de Chine] ; Runfeng Li [République populaire de Chine] ; Yang Zhou [Suède] ; Mengjie Xiao [République populaire de Chine] ; Chunlong Ma [États-Unis] ; Zhongjin Yang [République populaire de Chine] ; Shaogao Zeng [République populaire de Chine] ; Qiuling Du [République populaire de Chine] ; Chunguang Yang [République populaire de Chine] ; Haiming Jiang [République populaire de Chine] ; Yanmei Hu [États-Unis] ; Kefeng Wang [République populaire de Chine] ; Chris Ka Pun Mok [République populaire de Chine] ; Ping Sun [République populaire de Chine] ; Jianghong Dong [République populaire de Chine] ; Wei Cui [République populaire de Chine] ; Jun Wang [États-Unis] ; Yaoquan Tu [Suède] ; Zifeng Yang [République populaire de Chine] ; Wenhui Hu [République populaire de Chine]	Discovery of Highly Potent Pinanamine-Based Inhibitors against Amantadine- and Oseltamivir-Resistant Influenza A Viruses.
000390 (2017)	Xin Li [République populaire de Chine] ; Houbin Ju [République populaire de Chine] ; Jian Liu [République populaire de Chine] ; Dequan Yang [République populaire de Chine] ; Xinyong Qi [République populaire de Chine] ; Xianchao Yang [République populaire de Chine] ; Yafeng Qiu [République populaire de Chine] ; Jie Zheng [République populaire de Chine] ; Feifei Ge [République populaire de Chine] ; Jinping Zhou [République populaire de Chine]	Influenza virus-like particles harboring H9N2 HA and NA proteins induce a protective immune response in chicken.
000401 (2017)	Gale E. Smith [États-Unis] ; Xiangjie Sun [États-Unis] ; Yaohui Bai [États-Unis] ; Ye V. Liu [États-Unis] ; Michael J. Massare [États-Unis] ; Melissa B. Pearce [États-Unis] ; Jessica A. Belser [États-Unis] ; Taronna R. Maines [États-Unis] ; Hannah M. Creager [États-Unis] ; Gregory M. Glenn [États-Unis] ; David Flyer [États-Unis] ; Peter Pushko [États-Unis] ; Min Z. Levine [États-Unis] ; Terrence M. Tumpey [États-Unis]	Neuraminidase-based recombinant virus-like particles protect against lethal avian influenza A(H5N1) virus infection in ferrets.
000492 (2016)	Robert Moss [Australie] ; James M. Mccaw [Australie] ; Allen C. Cheng [Australie] ; Aeron C. Hurt [Australie] ; Jodie Mcvernon [Australie]	Reducing disease burden in an influenza pandemic by targeted delivery of neuraminidase inhibitors: mathematical models in the Australian context.
000516 (2016)	Dinah Henritzi [Allemagne] ; Na Zhao [Allemagne] ; Elke Starick [Allemagne] ; Gaelle Simon [France] ; Jesper S. Krog [Danemark] ; Lars Erik Larsen [Danemark] ; Scott M. Reid [Royaume-Uni] ; Ian H. Brown [Royaume-Uni] ; Chiara Chiapponi [Italie] ; Emanuela Foni [Italie] ; Silke Wacheck [Allemagne] ; Peter Schmid [Allemagne] ; Martin Beer [Allemagne] ; Bernd Hoffmann [Allemagne] ; Timm C. Harder [Allemagne]	Rapid detection and subtyping of European swine influenza viruses in porcine clinical samples by haemagglutinin- and neuraminidase-specific tetra- and triplex real-time RT-PCRs.
000522 (2016)	Emi Takashita [Japon] ; Miho Ejima [Japon] ; Rie Ogawa [Japon] ; Seiichiro Fujisaki [Japon] ; Gabriele Neumann [États-Unis] ; Yousuke Furuta [Japon] ; Yoshihiro Kawaoka [Japon] ; Masato Tashiro [Japon] ; Takato Odagiri [Japon]	Antiviral susceptibility of influenza viruses isolated from patients pre- and post-administration of favipiravir.
000537 (2016)	Zhimin Wan [République populaire de Chine] ; Jianqiang Ye [République populaire de Chine] ; Jianjun Sang [République populaire de Chine] ; Hongxia Shao [République populaire de Chine] ; Kun Qian [République populaire de Chine] ; Wenjie Jin [République populaire de Chine] ; Aijian Qin [République populaire de Chine] ; Hongquan Wan [République populaire de Chine]	Identification of amino acids in H9N2 influenza virus neuraminidase that are critical for the binding of two mouse monoclonal antibodies.
000628 (2015)	Julie Medina [France] ; Houda Boukhebza [France] ; Amélie De Saint Jean [France] ; Régis Sodoyer [France] ; Isabelle Legastelois [France] ; Catherine Moste [France]	Optimization of influenza A vaccine virus by reverse genetic using chimeric HA and NA genes with an extended PR8 backbone.
000635 (2015)	Nongluk Sriwilaijaroen [Oman] ; Katsuhiko Suzuki [Japon] ; Emi Takashita [Japon] ; Hiroaki Hiramatsu [Japon] ; Osamu Kanie [Japon] ; Yasuo Suzuki [Japon]	6SLN-lipo PGA specifically catches (coats) human influenza virus and synergizes neuraminidase-targeting drugs for human influenza therapeutic potential.
000712 (2015)	Anna Gillman [Suède] ; Shaman Muradrasoli [Suède] ; Hanna Söderström [Suède] ; Fredrik Holmberg [Suède] ; Neus Latorre-Margalef [Suède] ; Conny Tolf [Suède] ; Jonas Waldenström [Suède] ; Gunnar Gunnarsson [Suède] ; Björn Olsen [Suède] ; Josef D. J Rhult [Suède]	Oseltamivir-resistant influenza A (H1N1) virus strain with an H274Y mutation in neuraminidase persists without drug pressure in infected mallards.
000722 (2015)	Alex B. Ryder [États-Unis] ; Linda Buonocore [États-Unis] ; Leatrice Vogel [États-Unis] ; Raffael Nachbagauer [Autriche] ; Florian Krammer [États-Unis] ; John K. Rose [États-Unis]	A viable recombinant rhabdovirus lacking its glycoprotein gene and expressing influenza virus hemagglutinin and neuraminidase is a potent influenza vaccine.
000729 (2015)	Devanshi J. Gohil [Inde] ; Sweta T. Kothari [Inde] ; Pramod S. Shinde [Inde] ; Anand S. Chintakrindi [Inde] ; Rhuta Meharunkar [Inde] ; Rajas V. Warke [Inde] ; Meena A. Kanyalkar [Inde] ; Abhay S. Chowdhary [Inde] ; Ranjana A. Deshmukh [Inde]	Drug susceptibility of influenza A/H3N2 strains co-circulating during 2009 influenza pandemic: first report from Mumbai.
000747 (2014)	Michael L. Bentley ; Alan S. Hollistera ; Amanda C. Hansenb ; Jean A. Smith ; James S. Cain	Peramivir pharmacokinetics in a patient receiving continuous veno-venous hemodiafiltration during the 2009 H1N1 influenza A pandemic.
000823 (2014)	Tom Jefferson ; Peter Doshi	[Multisystem failure: the story of antinfluenza drugs].
000830 (2015)	Norio Sugaya [Japon] ; Yuko Sakai-Tagawa ; Masahiro Bamba ; Rieko Yasuhara ; Masahiko Yamazaki ; Chiharu Kawakami ; Yoshio Yamaguchi ; Yoshiaki Ide ; Masataka Ichikawa ; Keiko Mitamura ; Yoshihiro Kawaoka	Comparison between virus shedding and fever duration after treating children with pandemic A H1N1/09 and children with A H3N2 with a neuraminidase inhibitor.
000846 (2014)	Christine Hohenadl ; Walter Wodal ; Astrid Kerschbaum ; Richard Fritz ; M Keith Howard ; Maria R. Farcet ; Daniel Portsmouth ; John K. Mcvey ; Donald A. Baker ; Hartmut J. Ehrlich ; P Noel Barrett ; Thomas R. Kreil [Autriche]	Hyperimmune intravenous immunoglobulin containing high titers of pandemic H1N1 hemagglutinin and neuraminidase antibodies provides dose-dependent protection against lethal virus challenge in SCID mice.
000862 (2014)	Irina Isakova-Sivak [États-Unis] ; Li-Mei Chen ; Melissa Bourgeois ; Yumiko Matsuoka ; J Theo M. Voeten ; Jacco G M. Heldens ; Han Van Den Bosch ; Alexander Klimov ; Larisa Rudenko ; Nancy J. Cox ; Ruben O. Donis	Characterization of reverse genetics-derived cold-adapted master donor virus A/Leningrad/134/17/57 (H2N2) and reassortants with H5N1 surface genes in a mouse model.
000905 (2014)	Fawziah Marra [Canada] ; Mei Chong ; Bonnie Henry ; David M. Patrick ; Perry Kendall	Effectiveness of neuraminidase inhibitors in preventing hospitalization during the H1N1 influenza pandemic in British Columbia, Canada.

---

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Sante/explor/PandemieGrippaleV1/Data/PubMed/Curation

HfdIndexSelect -h $EXPLOR_AREA/Data/PubMed/Curation/MedMesh.i -k "Neuraminidase" 

HfdIndexSelect -h $EXPLOR_AREA/Data/PubMed/Curation/MedMesh.i  \
                -Sk "Neuraminidase" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/PubMed/Curation/biblio.hfd 

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Sante
   |area=    PandemieGrippaleV1
   |flux=    PubMed
   |étape=   Curation
   |type=    indexItem
   |index=    MedMesh.i
   |clé=    Neuraminidase
}}

---

This area was generated with Dilib version V0.6.34. Data generation: Wed Jun 10 11:04:28 2020. Site generation: Sun Mar 28 09:10:28 2021